Rosiglitazone maleate

Synonyms: BRL-49653C, BRL-49653

Rosiglitazone maleate, a member of the thiazolidinedione class of antihyperglycaemic agents, is a high-affinity selective agonist of the peroxisome proliferator-activated receptor-γ (PPAR-γ) with IC50 of 42 nM. Rosiglitazone maleate also modulates TRP channels and induces autophagy. Rosiglitazone prevents ferroptosis.

Rosiglitazone maleate Chemical Structure

Rosiglitazone maleate Chemical Structure

CAS No. 155141-29-0

Purity & Quality Control

Rosiglitazone maleate Related Products

Signaling Pathway

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HepG2 cells Function assay Peroxisome proliferator activated receptor gamma agonistic activity in HepG2 cells, EC50=0.73 μM 10714503
Click to View More Cell Line Experimental Data

Biological Activity

Description Rosiglitazone maleate, a member of the thiazolidinedione class of antihyperglycaemic agents, is a high-affinity selective agonist of the peroxisome proliferator-activated receptor-γ (PPAR-γ) with IC50 of 42 nM. Rosiglitazone maleate also modulates TRP channels and induces autophagy. Rosiglitazone prevents ferroptosis.
Targets
Ferroptosis [2] PPARγ [1]
42 nM
In vitro
In vitro

Rosiglitazone is an insulin-sensitising agent of the thiazolidinedione class of oral antihyperglycaemic drugs. Rosiglitazone exhibits insulin-sensitising activity 60- to 200-fold higher than that of troglitazone, englitazone, or piogliazone in rodent models of insulin ressitance. Rosiglitazone reduces hyperglycaemia by improving insulin sensitivity in adipose tissue, the liver and skeletal muscle tissue. Such insulin sensitisation may be partly attributable to the effects of Rosiglitazone on the expression of molecules involved in the insulin signalling cascade. In adipose tissue, Rosiglitazone-mediated PPARγ stimulation promotes adipocyte differentiation. Rosiglitazone may also promote the uptake of free fatty acids in adipose tissue, thus reducing systemic free fatty acid levels. The insulin sensitivity of the liver and peripheral tissues may be modulated indirectly by Rosiglitazone-mediated changes in levels of fatty acid or adipocyte-derived factors, such as adiponectin and TNFα. Rosiglitazone may also be involved in modulating the expression of adiponectin receptors in some tissues, which may be relevant to some aspects of insulin sensitisation. [1]

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02737709 Terminated
Non-small Cell Lung Cancer
Sun Yat-sen University
March 2016 Phase 2
NCT01402076 Completed
Healthy Volunteers
Vanda Pharmaceuticals
August 2011 Phase 1
NCT01415128 Completed
Erectile Dysfunction
VIVUS LLC
April 2010 Phase 1
NCT01100619 Completed
Papillary Thyroid Cancer|Follicular Thyroid Cancer|Huerthle Cell Thyroid Cancer|Renal Cell Carcinoma
Exelixis
April 2010 Phase 1
NCT01376063 Completed
Healthy Adult Subjects
FibroGen
March 2010 Phase 1

Chemical Information & Solubility

Molecular Weight 473.5 Formula

C18H19N3O3S.C4H4O4

CAS No. 155141-29-0 SDF Download Rosiglitazone maleate SDF
Smiles CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 95 mg/mL ( (200.63 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 6 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Rosiglitazone maleate | Rosiglitazone maleate ic50 | Rosiglitazone maleate price | Rosiglitazone maleate cost | Rosiglitazone maleate solubility dmso | Rosiglitazone maleate purchase | Rosiglitazone maleate manufacturer | Rosiglitazone maleate research buy | Rosiglitazone maleate order | Rosiglitazone maleate mouse | Rosiglitazone maleate chemical structure | Rosiglitazone maleate mw | Rosiglitazone maleate molecular weight | Rosiglitazone maleate datasheet | Rosiglitazone maleate supplier | Rosiglitazone maleate in vitro | Rosiglitazone maleate cell line | Rosiglitazone maleate concentration | Rosiglitazone maleate nmr